(Q43796487)

26 November 2017

Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy (English)

1 reference

hypertrophic obstructive cardiomyopathy

26 November 2017

0 references

author

Hartzell V. Schaff

6

1 reference

26 November 2017

7

Danielson GK

1 reference

26 November 2017

9

Tajik AJ

1 reference

26 November 2017

Nagueh SF

1

1 reference

26 November 2017

Ommen SR

2

1 reference

26 November 2017

Lakkis NM

3

1 reference

26 November 2017

Killip D

4

1 reference

26 November 2017

Zoghbi WA

5

1 reference

26 November 2017

Quiñones MA

8

1 reference

26 November 2017

Spencer WH

10

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Journal of the American College of Cardiology

26 November 2017

1 reference

26 November 2017

38

1 reference

26 November 2017

6

1 reference

26 November 2017

1701-1706

1 reference

Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Hypertrophic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Color Doppler assessment of mitral regurgitation with orthogonal planes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Evaluation of aortic insufficiency by Doppler color flow mapping

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Morphologic determinants of hemodynamic state after ventricular septal myotomy-myectomy in patients with obstructive hypertrophic cardiomyopathy: M mode and two-dimensional echocardiographic assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

New insights into the reduction of mitral valve systolic anterior motion after ventricular septal myectomy in hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901614-X

7 January 2021

10.1016/S0735-1097(01)01614-X

Identifiers

DOI

1 reference

26 November 2017

1 reference